• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    AptarGroup Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    7/25/24 5:25:14 PM ET
    $ATR
    Plastic Products
    Industrials
    Get the next $ATR alert in real time by email
    false 0000896622 0000896622 2024-07-22 2024-07-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    July 22, 2024
    Date of Report (Date of earliest event reported)

     

    AptarGroup, Inc.

    (Exact name of registrant as specified in its charter)

     

    Delaware
    (State or other jurisdiction of
    incorporation)
      1-11846
    (Commission File Number)
      36-3853103
    (IRS Employer Identification No.)

     

    265 Exchange Drive, Suite 301, Crystal Lake, Illinois 60014

    (Address of principal executive offices)

     

    Registrant’s telephone number, including area code: 815-477-0424

     

    N/A

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

      

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, $.01 par value   ATR   New York Stock Exchange

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company   ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ¨

     

     

     

     

     

     

    Item 5.02.              Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     

    On July 22, 2024, Robert W. Kuhn, Executive Vice President, Chief Financial Officer and Chief Accounting Officer of AptarGroup, Inc. (the “Company”), notified the Company that he will retire as the Company’s Executive Vice President and Chief Financial Officer on December 31, 2024, following the expiration of his employment agreement, and will retire as the Company’s principal accounting officer on July 31, 2024.

     

    On July 25, 2024, the Company announced that Vanessa Kanu will succeed Mr. Kuhn as Executive Vice President, Chief Financial Officer of the Company, effective January 1, 2025. Ms. Kanu, age 46, previously served from September 2020 until March 2024 as Chief Financial Officer of TELUS International and from May 2019 until August 2020 as Chief Financial Officer of Mitel Networks Corporation, where she spent 16 years in finance leadership roles. Prior to Mitel, Ms. Kanu spent over five years in the audit and business advisory services practice of PricewaterhouseCoopers. Ms. Kanu also serves as a director of Manulife Financial Corporation.

     

    On July 25, 2024, the Company announced that Daniel Ackerman, age 51, Vice President, Corporate Controller of the Company since 2015, will become the Company’s Chief Accounting Officer, effective August 1, 2024. In connection with this appointment, Mr. Ackerman will receive a restricted stock unit award under the Company’s 2018 Equity Incentive Plan (the “2018 Plan”) with a grant date fair value of $750,000, which is scheduled to vest on the third anniversary of the grant date, subject to Mr. Ackerman’s continued employment through such date and such other terms and conditions as are set forth in the Company’s customary restricted stock unit award agreement.

     

    There is no arrangement or understanding between Ms. Kanu or Mr. Ackerman and any other person pursuant to which either of them was appointed as an officer or director of the Company; there is no family relationship between either of them and any of the Company’s directors or other executive officers; and neither Ms. Kanu nor Mr. Ackerman is a party to any transactions of the type that would require disclosure under Item 404(a) of Regulation S-K.

     

    Vanessa Kanu Employment Agreement

     

    On July 24, 2024, the Company entered into an Employment Agreement with Ms. Kanu (the “Employment Agreement”) that contemplates a start date as soon as practicable following the date Ms. Kanu’s visa petition to work in the United States is approved, but in no event later than November 1, 2024 (such date, the “Effective Date”). Upon the Effective Date, Ms. Kanu will serve as Executive Vice President, Finance and Chief Financial Officer (Designate), reporting directly to the Company’s Chief Executive Officer and, effective January 1, 2025 or such other date as agreed to by the parties, Ms. Kanu will serve as Executive Vice President, Chief Financial Officer of the Company. The Employment Agreement provides for employment through December 31, 2027, unless terminated earlier. The Employment Agreement automatically extends for one additional year each January 1st beginning on January 1, 2026, but may not be extended beyond December 31, 2042.

     

    The Employment Agreement provides for an initial annual base salary of $720,000, which amount may be increased (but not decreased) over the term of the Employment Agreement. The Employment Agreement also provides that Ms. Kanu’s target annual performance incentive for 2025 will be set at 85% of her base salary, with the actual amount paid determined based on the level of attainment of certain goals and objectives. Beginning in 2025, Ms. Kanu will also be eligible to participate in the long-term incentive plan maintained for senior executive officers of the Company, with a target opportunity for calendar year 2025 equal to 310% of her base salary. Ms. Kanu is also entitled to participate in the Company’s retirement and executive benefit programs on the same basis as the Company’s other senior executives. In addition, the Company will (i) reimburse Ms. Kanu for reasonable moving expenses incurred in connection with her relocation to the Company's corporate headquarters in accordance with the Company's relocation practices for senior executive officers, (ii) reimburse Ms. Kanu for pre-approved temporary living expenses (including food and lodging) for her and her family for a maximum of 60 consecutive days, (iii) reimburse Ms. Kanu for expenses associated with her application for a U.S. O-1 visa and (iv) pay Ms. Kanu within 60 days of the Effective Date an amount equal to one month of her base salary as a miscellaneous expense allowance.

     

    The Employment Agreement also provides that the Company will make a sign-on cash payment to Ms. Kanu in the amount of $300,000 (less applicable taxes and withholding) in a lump sum within 60 days of the Effective Date, subject to her continued employment with the Company through the payment date (the “Sign-on Bonus”). The Sign-On Bonus is subject to repayment if Ms. Kanu’s employment is terminated within 24 months following the Effective Date for any reason other than by the Company without “cause” or by Ms. Kanu for “good reason” (each as defined in the Employment Agreement). In addition, within 60 days of the Effective Date, subject to the approval of the Board of Directors of the Company (the “Board”) (or a committee thereof) and Ms. Kanu’s continued employment with the Company through such date, the Company will grant to Ms. Kanu a restricted stock unit award under the 2018 Plan with a grant date fair value equal to $700,000, which will be scheduled to vest 100% on the three-year anniversary of the Effective Date, subject to Ms. Kanu’s continued employment through such date and such other terms and conditions as are set forth in the Company’s customary restricted stock unit award agreement.

     

     

     

     

    If Ms. Kanu’s employment ends on account of death, Ms. Kanu’s estate will receive one-half of the base salary that Ms. Kanu would have received until the second anniversary of her death. If her employment ends due to the expiration of the Employment Agreement following a delivery by the Company of a notice of non-extension, Ms. Kanu is entitled to receive an amount equal to one year's base salary and the medical and life insurance benefits she would have otherwise received for a period of one year following the expiration date. If Ms. Kanu is terminated without “cause,” she is entitled to receive an amount equal to the base salary she would have received had the employment period remained in effect until the date on which it was then scheduled to end. In addition, if Ms. Kanu’s employment terminates for any reason other than by the Company for “cause” during the third or fourth quarter of the Company’s fiscal year, she will also be entitled to a prorated annual bonus based on actual performance for the year in which the termination occurs.

     

    After a “change in control” (as defined in the Employment Agreement), if Ms. Kanu’s employment is terminated by the Company or its successor other than for “cause,” disability or death, or if Ms. Kanu terminates her employment for “good reason,” in each case, within two years following the change in control, Ms. Kanu is entitled to receive a lump-sum payment equal to (i) two times her highest annualized salary during the 12 month period preceding the termination and (ii) two times the average of the annual performance incentives in respect of the three years immediately preceding the year in which the change in control occurs, plus a prorated annual performance incentive equal to an amount at least equal to the average of the annual performance incentives in respect of the three years immediately preceding the year in which the change in control occurs, as well as the continuation of medical, disability and life insurance benefits for two years and a payment in respect of any accrued but unused vacation pay.

     

    The Employment Agreement also contains certain noncompetition and nonsolicitation covenants prohibiting Ms. Kanu from, among other things, becoming employed by a competitor of the Company for a period of one or two years following termination (depending on the nature of the termination).

     

    The foregoing description of the Employment Agreement is qualified in its entirety by reference to the full text of the Employment Agreement, a copy of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.

     

    In order to facilitate a transition of responsibilities following Mr. Kuhn’s over 15 years of service as the Company’s Executive Vice President and Chief Financial Officer, the Company and Mr. Kuhn entered into a one-year transition and advisor agreement entitling Mr. Kuhn to a monthly advisory fee of $10,000 for each month of service as an advisor.

     

    Item 7.01              Regulation FD Disclosures

     

    On July 25, 2024, the Company issued press releases regarding the matters described in Item 5.02 of this report, which are furnished as Exhibits 99.1 and 99.2 to this report.

     

     

     

     

    Item 9.01.               Financial Statements and Exhibits.

     

    (d)      Exhibits

     

    Exhibit No.   Description  
    10.1 Employment Agreement dated as of July 24, 2024 between AptarGroup, Inc. and Vanessa Kanu.
    99.1 Press release issued  by AptarGroup, Inc. dated July 25, 2024 relating to Robert Kuhn and Vanessa Kanu.
    99.2 Press release issued by AptarGroup, Inc. dated July 25, 2024 relating to Daniel Ackerman.
    104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      AptarGroup, Inc.
       
    Date: July 25, 2024 By: /s/ Kimberly Y. Chainey
        Kimberly Y. Chainey
       

    Executive Vice President, Chief Legal Officer and

    Corporate Secretary

     

     

    Get the next $ATR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATR

    DatePrice TargetRatingAnalyst
    3/20/2026$144.00Equal Weight → Overweight
    Wells Fargo
    1/6/2026$133.00Overweight → Equal Weight
    Wells Fargo
    11/3/2025Outperform → Mkt Perform
    William Blair
    9/4/2025$220.00Overweight
    KeyBanc Capital Markets
    1/7/2025$200.00Outperform
    Raymond James
    1/6/2025$173.00Buy → Neutral
    BofA Securities
    10/14/2024$155.00 → $215.00Hold → Buy
    Jefferies
    4/29/2024Mkt Perform → Outperform
    William Blair
    More analyst ratings

    $ATR
    SEC Filings

    View All

    SEC Form DEFA14A filed by AptarGroup Inc.

    DEFA14A - APTARGROUP, INC. (0000896622) (Filer)

    3/27/26 8:09:34 AM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form DEF 14A filed by AptarGroup Inc.

    DEF 14A - APTARGROUP, INC. (0000896622) (Filer)

    3/27/26 8:08:53 AM ET
    $ATR
    Plastic Products
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by AptarGroup Inc.

    SCHEDULE 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    3/26/26 3:44:59 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    AptarGroup upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded AptarGroup from Equal Weight to Overweight and set a new price target of $144.00

    3/20/26 8:27:39 AM ET
    $ATR
    Plastic Products
    Industrials

    AptarGroup downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded AptarGroup from Overweight to Equal Weight and set a new price target of $133.00

    1/6/26 8:44:42 AM ET
    $ATR
    Plastic Products
    Industrials

    AptarGroup downgraded by William Blair

    William Blair downgraded AptarGroup from Outperform to Mkt Perform

    11/3/25 9:08:28 AM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Tlili Hedi

    4 - APTARGROUP, INC. (0000896622) (Issuer)

    3/20/26 2:24:51 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form 4 filed by Kanu Vanessa

    4 - APTARGROUP, INC. (0000896622) (Issuer)

    3/20/26 2:22:49 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form 4 filed by Tanda Stephan B.

    4 - APTARGROUP, INC. (0000896622) (Issuer)

    3/19/26 8:20:10 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aptar's Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray

    Use of Aptar Pharma's UDS Powder system supports the development of a next‑generation, virus‑agnostic nasal spray being evaluated for its potential to help protect against symptomatic viral respiratory infections AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that its Unidose (UDS) Powder Nasal Spray System is being utilized in ENA Respiratory's Phase II clinical study of INNA 051, an investigational nasal spray being evaluated for its potential to help protect against symptomatic viral respiratory infections. This collaboration reflects the growing role of intranasal delivery technologies

    3/19/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that Gael Touya, a seasoned global executive with more than 30 years of experience at the company, most recently as Aptar Pharma President, has been appointed President and Chief Executive Officer, effective September 1, 2026. He will succeed Stephan B. Tanda, who has served as President and Chief Executive Officer since 2017. Stephan is expected to continue to work closely with Gael and the Board as an advisor through the end of the year to help ensure a seamless transition as the company enters its next phase of growth. Stephan intends to reti

    3/17/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar's Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN® Nasal Spray

    Supporting advancement of complex intranasal therapies through clinical development AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that its proprietary nasal delivery system is being utilized in LTR Pharma Limited's (ASX:LTP) Phase II clinical study of SPONTAN®, an investigational intranasal spray under development for the treatment of erectile dysfunction. This milestone reflects Aptar Pharma's continued commitment to supporting intranasal drug delivery technologies and supporting the development of innovative, patient-centric therapies. This press release features multimedia. View the f

    3/16/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Leadership Updates

    Live Leadership Updates

    View All

    Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that Gael Touya, a seasoned global executive with more than 30 years of experience at the company, most recently as Aptar Pharma President, has been appointed President and Chief Executive Officer, effective September 1, 2026. He will succeed Stephan B. Tanda, who has served as President and Chief Executive Officer since 2017. Stephan is expected to continue to work closely with Gael and the Board as an advisor through the end of the year to help ensure a seamless transition as the company enters its next phase of growth. Stephan intends to reti

    3/17/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar CFO, Robert (Bob) Kuhn, Has Decided to Step Down After 37 Years with the Company

    Aptar Names Vanessa Kanu, A Finance Veteran with Over 25 Years of Experience, as Next CFO AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Bob Kuhn, Executive Vice President and Chief Financial Officer (CFO) since 2008, has decided to retire at the end of this year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240725873916/en/(Left to right) Bob Kuhn, Executive Vice President and Chief Financial Officer since 2008, has decided to retire at the end of 2024; Vanessa Kanu will become Executive Vice President and CFO on January 1, 2025,

    7/25/24 5:20:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Appoints Global Finance and Operations Veteran Sarah Glickman to its Board of Directors

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Sarah Glickman, an accomplished leader with more than 30 years of global financial and operational experience, has joined its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230905451175/en/Sarah Glickman Joins Aptar's Board of Directors (Photo: Aptar) "We are pleased to welcome Sarah Glickman to our Board of Directors. Sarah's extensive knowledge of all aspects of corporate finance coupled with her global operational experience, including in the pharmaceutical industry

    9/5/23 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Financials

    Live finance-specific insights

    View All

    Aptar Reports Fourth Quarter and Annual 2025 Results

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today reported the following fourth quarter results for the period ended December 31, 2025, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260205227722/en/Photo: Aptar Fourth Quarter 2025 Highlights (Compared to the prior year quarter; see Non-GAAP section for full definitions; see reconciliation for Non-GAAP measures) Reported sales increased 14% and core sales increased 5%—all three segments delivered core sales growth Reporte

    2/5/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced that the Board declared a quarterly cash dividend of $0.48 per share. The payment date is February 25, 2026, to stockholders of record as of February 4, 2026. As previously announced, Aptar will hold a conference call on Friday, February 6, 2026, at 8:00 a.m. Central Time to discuss the Company's fourth quarter and year-end results for 2025. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. A replay of the conference call can also be accessed fo

    1/22/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Announces 2026 Quarterly Conference Call Dates

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases. Quarterly Conference Calls   Press Release(1) Conference Call(2) 4th Quarter and Annual 2025 Results February 5, 2026 February 6, 2026, at 8:00 a.m. CT 1st Quarter 2026 Results April 30, 2026 May 1, 2026, at 8:00 a.m. CT 2nd Quarter 2026 Results July 30, 2026 July 31, 2026, at 8:00 a.m. CT 3rd Quarter 2026 Results

    1/7/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/13/24 4:58:57 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/12/24 3:08:10 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/12/24 11:53:37 AM ET
    $ATR
    Plastic Products
    Industrials